Tau‐inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Filamentous tau‐positive inclusions in neurons and glia are a unifying mechanism underlying a variety of late onset neurodegenerative disorders termed “tauopathies”. Oligodendroglial lesions and white matter pathology have long been underestimated and are specifically prominent in frontotemporal dementias (FTDs), such as Pick's disease (PiD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP‐17). Oligodendrocytes contain an extensive microtubule network and express the microtubule‐associated protein tau. Tau‐positive inclusion bodies in oligodendrocytes are postively stained with antibodies against ubiquitin and heat shock proteins (HSPs). Specifically the small HSP αB‐crystallin has been identified in oligodendroglial lesions. HSPs act as molecular chaperones and prevent the accumulation of abnormal proteins, and support proteolytic degradation by targeting non‐reparable proteins to the ubiquitin proteasomal pathway. HSPs and the proteasomal system closely work together. The present report summarizes recent data on HSP induction and aggregate formation in oligodendroglia cell culture systems, indicating that posttranslational modification of tau, HSP induction and alterations of the proteasomal system, which might occur during aging and disease processes, are involved in the neuropathological events leading to aggregate formation and degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aggresomes: A Cellular Response to Misfolded Proteins
Johnston, J. A., Ward, C. L., & Kopito, R. R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.7.1883 · Cited by 2,148 · cited 3×
“The studies mentioned were carried out with embryonic kidney, Chinese hamster ovary or COS cells, and the aggresomes were ensheathed in a cage-like structure consisting of the intermediate filament (IF) protein vimentin, pointing to a role of IF reorganization in the aggregation process (Johnston et al., 1998; Garcia-…”
BackgroundAge-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968 · cited 2×
“An age-related myelin breakdown, which specifically seems to affect fibers which have been myelinated later in development, has been suggested to be at the core of pathological processes during aging and neurodegenerative diseases with cognitive deficits (Braak and Del Tredici, 2004; Bartzokis, 2004).”
BackgroundTu, P., Galvin, J. E., Baba, M., Giasson, B., Tomita, T., Leight, S., Nakajo, S., Iwatsubo, T., Trojanowski, J. Q., & Lee, V. M. ‐. (1998) · Annals of Neurology · doi:10.1002/ana.410440324 · Cited by 686 · cited 1×
“Although asynuclein is the major building block of GCIs, various reports demonstrate the presence of tau (Cairns et al., 1997; Tu et al., 1998).”
BackgroundOn the role of Hsp27 in regulating apoptosis
Concannon, C. G., Gorman, A. M., & Samali, A. (2003) · Apoptosis · doi:10.1023/a:1021601103096 · Cited by 513 · cited 2×
“These small HSPs not only assist in preventing non-physiological protein– protein interactions and possibly aggregate formation in stress conditions, but also play a role in modulating cellular redox state and regulate cell death and survival by interacting with key components of the apoptotic pathway (Haslbeck, 2002;…”
BackgroundUbiquitin, cellular inclusions and their role in neurodegeneration
Alves-Rodrigues, A., Gregori, L., & Figueiredo-Pereira, M. E. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01276-4 · Cited by 393
LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10369 · Cited by 388
Tofaris, G. K., Layfield, R., & Spillantini, M. G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03115-5 · Cited by 363 · cited 1×
“Non-ubiquitinated forms of tau and a-synuclein have recently been described to be degradable by the proteasome (David et al., 2002; Tofaris et al., 2001).”
BackgroundProteasomal degradation of tau protein
David, D. C., Layfield, R., Serpell, L., Narain, Y., Goedert, M., & Spillantini, M. G. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01137.x · Cited by 327 · cited 1×
“Non-ubiquitinated forms of tau and a-synuclein have recently been described to be degradable by the proteasome (David et al., 2002; Tofaris et al., 2001).”
BackgroundKeller, J. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(01)00006-x · Cited by 247
Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes
Müller, R., Heinrich, M., Heck, S., Blohm, D., & Richter-Landsberg, C. (1997) · Cell and Tissue Research · doi:10.1007/s004410050809 · Cited by 127
Self-citation
Cited by
Krylova, S. M., Musheev, M., Nutiu, R., Li, Y., Lee, G., & Krylov, S. N. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.01.032 · Cited by 96
“Tau is also involved in a number of pathological conditions, such as Alzheimer and Parkinson diseases, although the exact molecular mechanisms of this involvement are still debated [3–5].”
BackgroundThe Cytoskeleton in Oligodendrocytes: Microtubule Dynamics in Health and Disease
Richter-Landsberg, C. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-9017-7 · Cited by 89
Self-citationJänen, S. B., Chaachouay, H., & Richter‐Landsberg, C. (2010) · Glia · doi:10.1002/glia.21047 · Cited by 87
Self-citation
Metadata
- Authors
- Richter‐Landsberg, C., & Bauer, N. G.
- Venue
- International Journal of Developmental Neuroscience
- Publisher
- Wiley
- Published
- 2004-08-20
- Volume
- 22
- Issue
- 7
- Pages
- 443-451
- ISSN
- 0736-5748 (ISSN-L)
- 1873-474X
- OpenAlex
- W2084505969
- Cited by
- 49
- References
- 10
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.